Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Population Health | 3 | 2024 | 35 | 1.830 |
Why?
|
| Genomics | 15 | 2024 | 1458 | 1.360 |
Why?
|
| Pharmacogenetics | 5 | 2024 | 180 | 1.340 |
Why?
|
| Laboratories | 3 | 2024 | 83 | 0.870 |
Why?
|
| Genetic Testing | 6 | 2021 | 978 | 0.720 |
Why?
|
| Computer Security | 1 | 2019 | 26 | 0.670 |
Why?
|
| Medical Records | 1 | 2019 | 189 | 0.640 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 3050 | 0.630 |
Why?
|
| Proteins | 7 | 2013 | 1043 | 0.590 |
Why?
|
| Genome, Human | 6 | 2021 | 1248 | 0.500 |
Why?
|
| Neptune | 1 | 2021 | 4 | 0.390 |
Why?
|
| Protein Conformation | 5 | 2015 | 831 | 0.330 |
Why?
|
| Genetic Variation | 4 | 2024 | 1462 | 0.320 |
Why?
|
| Databases, Protein | 6 | 2015 | 56 | 0.310 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 1822 | 0.310 |
Why?
|
| Electronic Health Records | 4 | 2023 | 691 | 0.310 |
Why?
|
| Software | 5 | 2021 | 670 | 0.300 |
Why?
|
| Evolution, Molecular | 6 | 2015 | 669 | 0.300 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2024 | 860 | 0.280 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 457 | 0.280 |
Why?
|
| Sequence Analysis, Protein | 3 | 2015 | 49 | 0.260 |
Why?
|
| Precision Medicine | 3 | 2024 | 306 | 0.260 |
Why?
|
| Computational Biology | 5 | 2020 | 789 | 0.250 |
Why?
|
| Clinical Laboratory Services | 1 | 2024 | 19 | 0.230 |
Why?
|
| Genetics, Medical | 2 | 2021 | 117 | 0.220 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2024 | 262 | 0.200 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 31 | 0.200 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2023 | 84 | 0.200 |
Why?
|
| United States | 5 | 2024 | 10487 | 0.190 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 70 | 0.190 |
Why?
|
| Pancreatitis | 1 | 2022 | 130 | 0.180 |
Why?
|
| Whole Genome Sequencing | 1 | 2022 | 279 | 0.180 |
Why?
|
| Humans | 24 | 2024 | 122296 | 0.180 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 137 | 0.170 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2020 | 8 | 0.170 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 26 | 0.170 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 33 | 0.170 |
Why?
|
| Medical Informatics | 1 | 2021 | 107 | 0.170 |
Why?
|
| Gastritis | 1 | 2022 | 371 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2020 | 237 | 0.160 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 141 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 3 | 2013 | 144 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2020 | 191 | 0.150 |
Why?
|
| Enzymes | 4 | 2013 | 51 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 741 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2018 | 184 | 0.130 |
Why?
|
| Exome | 1 | 2021 | 1009 | 0.130 |
Why?
|
| Exons | 1 | 2019 | 793 | 0.130 |
Why?
|
| Cardiology | 1 | 2021 | 468 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 2573 | 0.120 |
Why?
|
| Algorithms | 5 | 2013 | 1575 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 867 | 0.120 |
Why?
|
| Cohort Studies | 4 | 2021 | 4643 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 365 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 738 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 928 | 0.110 |
Why?
|
| Phenotype | 2 | 2020 | 4151 | 0.110 |
Why?
|
| Pharmacogenomic Testing | 2 | 2024 | 36 | 0.110 |
Why?
|
| Molecular Biology | 1 | 2013 | 78 | 0.100 |
Why?
|
| Proteome | 2 | 2013 | 234 | 0.100 |
Why?
|
| Biochemistry | 1 | 2010 | 11 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2010 | 106 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2796 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2010 | 386 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 887 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2020 | 1750 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2010 | 447 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2010 | 747 | 0.070 |
Why?
|
| Proteomics | 1 | 2010 | 475 | 0.070 |
Why?
|
| Genotype | 2 | 2024 | 2525 | 0.070 |
Why?
|
| Neoplasms | 1 | 2020 | 2753 | 0.070 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 66 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2024 | 36 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2024 | 60 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2024 | 703 | 0.050 |
Why?
|
| Penetrance | 1 | 2023 | 100 | 0.050 |
Why?
|
| Minority Groups | 1 | 2024 | 249 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2023 | 67 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2024 | 463 | 0.050 |
Why?
|
| Health Level Seven | 1 | 2021 | 3 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2024 | 581 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 227 | 0.050 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2020 | 8 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 297 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 712 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 312 | 0.040 |
Why?
|
| Reference Values | 1 | 2021 | 698 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2023 | 5963 | 0.040 |
Why?
|
| Acute Disease | 1 | 2022 | 1090 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 139 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 226 | 0.040 |
Why?
|
| Computer Communication Networks | 1 | 2018 | 15 | 0.040 |
Why?
|
| Polyps | 1 | 2018 | 48 | 0.040 |
Why?
|
| Cardiac Myosins | 1 | 2017 | 10 | 0.040 |
Why?
|
| Tropomyosin | 1 | 2017 | 21 | 0.040 |
Why?
|
| Connectin | 1 | 2017 | 26 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2017 | 58 | 0.040 |
Why?
|
| Base Sequence | 1 | 2022 | 3109 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 431 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 77 | 0.040 |
Why?
|
| Male | 5 | 2022 | 59522 | 0.040 |
Why?
|
| Syndrome | 1 | 2020 | 1109 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 174 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 146 | 0.030 |
Why?
|
| Prevalence | 1 | 2023 | 2371 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1533 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 28733 | 0.030 |
Why?
|
| Colon | 1 | 2018 | 348 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2017 | 415 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 523 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 83 | 0.030 |
Why?
|
| Female | 4 | 2022 | 64883 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2013 | 23 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 175 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 767 | 0.030 |
Why?
|
| Myocardium | 1 | 2017 | 980 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1015 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 550 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 284 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3307 | 0.020 |
Why?
|
| Forecasting | 1 | 2013 | 355 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2009 | 26 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 2817 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 9902 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 654 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3626 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 25640 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2009 | 613 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 873 | 0.020 |
Why?
|
| Phylogeny | 1 | 2009 | 681 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2009 | 1068 | 0.020 |
Why?
|
| Internet | 1 | 2009 | 373 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2020 | 13777 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 8760 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 33721 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 5734 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 18785 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 18940 | 0.010 |
Why?
|
| Child | 1 | 2017 | 24064 | 0.010 |
Why?
|